Company
Red Ace Bio
Reprogramming tumors with synthetic vulnerabilities to overcome drug resistance and enable lasting cancer remission
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Reprogramming tumors with synthetic vulnerabilities to overcome drug resistance and enable lasting cancer remission
Loading relationship preview